Search results
Results from the WOW.Com Content Network
IQVIA, formerly Quintiles and IMS Health, Inc., [6] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
IMS Health v. Ayotte was a free speech case involving IMS Health. [28] [29] [30] Sorrell v. IMS Health Inc. was a case about physician-data privacy, which went to the U.S. Supreme Court., the High Court ruled in favor of the company. [31] [32] [33] [34]
The Income Tax Act defines SR&ED. The Canada Revenue Agency (CRA) is responsible for its administration. The CRA Information Circular 86-4R3 is a key document that provides technical guidelines to clarify and interpret the language in the tax act. CRA Interpretation Bulletin IT-151-R4 is a key document that explains SR&ED expenditures.
In 1994, he took Quintiles public through an IPO. [6] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6]
In 2008, he became director of Quintiles Transnational Corp, a healthcare company in the field of clinical research. [5] In 2016, Quintiles merged with IMS Health, a health IT company, to become IQVIA. Connaughton became a director of IQVIA in October of that year. [5] Connaughton was appointed to the board of HCA Healthcare for a term through ...
According to the OECD, 'household disposable income is income available to households such as wages and salaries, income from self-employment and unincorporated enterprises, income from pensions and other social benefits, and income from financial investments (less any payments of tax, social insurance contributions and interest on financial ...
The Royce Consultancy the UK's leading privately held pharmaceutical sales representative recruitment and contract sales organisation (CSO). [1]Royce was founded in 1983 and is the largest healthcare and pharmaceutical recruitment company in the UK.
As an example (and not including locality adjustments), an employee at GS-12 Step 10 (base salary $98,422) being promoted to a GS-13 position would initially have his/her salary set at GS-13 Step 4 (base salary $99,028, as it is the nearest salary to GS-12 Step 10 but not lower than it), and then have his/her salary adjusted to a higher step ...